Effect of Discharge Via an Intermediate Care Unit

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01706744
First received: October 11, 2012
Last updated: December 7, 2015
Last verified: December 2015

October 11, 2012
December 7, 2015
February 2010
December 2013   (final data collection date for primary outcome measure)
  • Hospital readmission [ Time Frame: 30 days ] [ Designated as safety issue: No ]
    Acute admission to hospital within 30 days from previous discharge
  • Use of local health care services [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01706744 on ClinicalTrials.gov Archive Site
  • death [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]
  • hospital admission [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]
  • functional assessment status [ Time Frame: up to 6 months ] [ Designated as safety issue: No ]
  • Health service cost [ Time Frame: up to 1 year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Effect of Discharge Via an Intermediate Care Unit
Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study

The main goal is to investigate the following topics:

  1. Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital?
  2. Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital?
  3. Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
  • Patients
  • Aged
  • Other: Intermediate care unit
  • Other: Local health care 1
  • Other: Local health care 2
  • Experimental: Intermediate care unit
    Follow-up treatment and care in a intermediate care unit after discharge from hospital
    Intervention: Other: Intermediate care unit
  • Active Comparator: Local health care 1
    Discharge from hospital to usual care as provided by the local health and social care (Verdal)
    Intervention: Other: Local health care 1
  • Active Comparator: Local health care 2
    Discharge from hospital to usual care as provided by the local health and social care (Stjørdal)
    Intervention: Other: Local health care 2

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
328
December 2013
December 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

Patients 60 years old or older from Stjørdal- or Verdal municipality,

  • given consent,
  • admitted from their home,
  • diagnostics completed and necessary treatment started
  • the patient need not less than 3-4 days institutionalization for treatment/rehabilitation/care

Exclusion Criteria:

  • Patients with severe dementia
  • Patients with severe disease who cannot give consent
  • Patients with severe disease with short life expectancy (including severe cancer)
Both
60 Years to 99 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT01706744
2009/1697
No
Not Provided
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Not Provided
Study Director: Roar Johnsen, PhD Norwegian University of Science and Technology
Norwegian University of Science and Technology
December 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP